SAN DIEGO, September 29, 2025--t:slim X2 insulin pump with Control-IQ+ technology now cleared for use with Lyumjev ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi ...

Earnings Call Insights: Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Updated 2025 guidance projects $1 billion in worldwide sales, with approximately $700 million from the U.S. and $300 million ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated ...

During the last three months, 4 analysts shared their evaluations of Tandem Diabetes Care TNDM, revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada authorization for distribution of the Tandem t:slim mobile ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2025 results after the financial markets close on Wednesday, ...